# FDA Inspection 1166601 - Neelam Dhiman, PhD - March 30, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/neelam-dhiman-phd/1b72a333-64b4-4f2a-b641-89c3e1c31c1d
Source feed: FDA_Inspections

> FDA Inspection 1166601 for Neelam Dhiman, PhD on March 30, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166601
- Company Name: Neelam Dhiman, PhD
- Inspection Date: 2022-03-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1166601 - 2022-03-30](https://www.globalkeysolutions.net/records/fda_inspections/neelam-dhiman-phd/df1b7368-ba30-4cb5-b309-b48bfc99aa17)

Company: https://www.globalkeysolutions.net/companies/neelam-dhiman-phd/b8f0a55c-37ba-415c-bca2-0550d4f83226

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d